Previous close | 3.6400 |
Open | 3.5400 |
Bid | 2.7600 x 200 |
Ask | 4.5400 x 200 |
Day's range | 3.5400 - 3.8200 |
52-week range | 1.5300 - 5.9270 |
Volume | |
Avg. volume | 44,574 |
Market cap | 37.488M |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.6700 |
Earnings date | 29 Apr 2024 - 04 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
LOS ANGELES, April 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Nutriband Inc. (NASDAQ: NTRB), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has selected IBN, a multifaceted financial news and publishing company for private and public entities, to assist with its corporate communications initiatives. Nutriband’s AVERSA™ technology can be incorporated into any transdermal patch and includes aversive agents to prevent abuse, diversion, misuse and accident
Nutriband ( NASDAQ:NTRB ) Full Year 2023 Results Key Financial Results Revenue: US$2.08m (up 46% from FY 2022). Net...